DR. THOMAS EDGAR HUTSON DOPHARMD NPI 1609819069

NPI Information

  • NPI: 1609819069
  • Provider Name: DR. THOMAS EDGAR HUTSON, DO,PHARMD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3410 WORTH ST
    DALLAS, TX
    ZIP 75246
  • Phone: (214) 370-1000

Map and Directions

Get Directions

NPI Details

DR. Thomas Edgar Hutson, DO,PHARMD is a medical oncology internal medicine in Dallas, TX with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Thomas Edgar Hutson, DO,PHARMD NPI is 1609819069. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OHIO UNIVERSITY, COLLEGE OF OSTEOPATHIC MEDICINE
Graduation Year:1997

The provider's business location address is:

3410 WORTH ST
DALLAS, TX
ZIP 75246-003
Phone: (214) 370-1000
Fax: (214) 370-1202

The NPI 1609819069 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Unclassified drugs (HCPCS:J3490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Albumin (protein) level (HCPCS:82040)
  • Bilirubin level, total (HCPCS:82247)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Total protein level, blood (HCPCS:84155)
  • Liver enzyme (sgot), level (HCPCS:84450)

The enumeration date for this NPI number is 6/14/2006 and was last updated on 9/1/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyL5774TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1H06858MEDICARE UPINTEXAS
2163058401MEDICAIDTEXAS
38B3539MEDICARE PINTEXAS
48D4934MEDICARE PINTEXAS
5P00076038MEDICARE PINTENNESSEE
68R1471OTHERTEXASBLUE CROSS OF TX
7163058402MEDICAIDTEXAS
8163058403MEDICAIDTEXAS
98C0110MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.